Private Market View

Metsera

Drug Discovery

Last price · $/share
Implied valuation
Total raised
$215.0M
Last round
Early Stage VC (Series B)
Nov 2024
Valuation — not yet established

No valuation for Metsera is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($215.0M) and the funding record below are the closest available signals.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
  • ·Post-money valuations for all 1 rounds
  • ·Watchlist + deal alerts for Metsera
Create free account
No card required

Funding history

1 rounds
DateRoundRaisedPost-money
Nov 2024Early Stage VC (Series B)$215.0M

How Metsera's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Metsera, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked

How much has Metsera raised?
Metsera has raised $215.0M in total funding across 1 recorded rounds.
When did Metsera last raise?
Metsera last raised in Nov 2024 (Early Stage VC (Series B)), raising $215.0M.